T1	Participants 72 128	in postmenopausal breast cancer survivors with bone loss
T2	Participants 367 412	in 223 postmenopausal breast cancer survivors
T3	Participants 568 683	postmenopausal breast cancer survivors (BCS) with bone loss taking 24 months of risedronate, calcium, and vitamin D
T4	Participants 1385 1430	women who took medications without exercising
T5	Participants 1584 1608	Women who also exercised
T6	Participants 2131 2174	in postmenopausal BCS at risk for bone loss
